A new class of potent non-imidazole H3 antagonists:: 2-aminoethylbenzofurans

被引:80
作者
Cowart, M [1 ]
Pratt, JK [1 ]
Stewart, AO [1 ]
Bennani, YL [1 ]
Esbenshade, TA [1 ]
Hancock, AA [1 ]
机构
[1] Abbott Labs, Dept Neurosci Res, Abbott Pk, IL 60064 USA
关键词
D O I
10.1016/j.bmcl.2003.11.032
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
2-Aminoethylbenzofurans constitute a new class of H-3 antagonists that are more rotationally constrained than most previously reported H-3 antagonists. They retain high potency at human and rat receptors, with efficient CNS penetration observed in 35. The SAR of the basic amine moiety was compared in three different series of analogues. The greatest potency was found in analogues bearing a 2-methylpyrrolidine, a 2,5-dimethylpyrrolidine, or a 2,6-dimethylpiperidine. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:689 / 693
页数:5
相关论文
共 33 条
[1]  
Bjenning C, 2001, INT CONGR SER, V1224, P451
[2]  
Boxenbaum H, 1999, J PHARM PHARM SCI, V2, P47
[3]  
BROWN RE, 2001, PHARMACOL REV, V38, P279
[4]   Non-imidazole heterocyclic histamine H3 receptor antagonists [J].
Chai, WY ;
Breitenbucher, JG ;
Kwok, A ;
Li, XB ;
Wong, V ;
Carruthers, NI ;
Lovenberg, TW ;
Mazur, C ;
Wilson, SJ ;
Axe, FU ;
Jones, TK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (10) :1767-1770
[5]  
COWART M, 2003, UNPUB MINIREVIEWS ME
[6]   Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides:: Novel and selective histamine H3 receptor antagonists [J].
Faghih, R ;
Dwight, W ;
Pan, JB ;
Fox, GB ;
Krueger, KM ;
Esbenshade, TA ;
McVey, JM ;
Marsh, K ;
Bennani, YL ;
Hancock, AA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (07) :1325-1328
[7]   Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands [J].
Faghih, R ;
Dwight, W ;
Vasudevan, A ;
Dinges, J ;
Conner, SE ;
Esbenshade, TA ;
Bennani, YL ;
Hancock, AA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) :3077-3079
[8]   Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920:: II.: In vivo behavioral and neurophysiological characterization [J].
Fox, GB ;
Pan, JB ;
Radek, RJ ;
Lewis, AM ;
Bitner, RS ;
Esbenshade, TA ;
Faghih, R ;
Bennani, YL ;
Williams, M ;
Yao, BB ;
Decker, MW ;
Hancock, AA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03) :897-908
[9]  
Ganellin CR, 1998, ARCH PHARM, V331, P395, DOI 10.1002/(SICI)1521-4184(199812)331:12<395::AID-ARDP395>3.0.CO
[10]  
2-7